Hongo Hiroki, Miyawaki Satoru, Saito Nobuhito
Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Acta Neurochir Suppl. 2025;136:143-149. doi: 10.1007/978-3-031-89844-0_18.
Cerebral cavernous malformations (CCMs) are vascular anomalies affecting the central nervous system in up to 0.5% of the population. These lesions are characterised by thin-walled, dilated blood vessels that are susceptible to haemorrhage. They can cause several symptoms, such as epileptic seizures, haemorrhagic strokes, and focal neurological deficits. Clinical studies have revealed the epidemiology and natural history of CCMs. Human genetic studies have identified CCM1, CCM2, and CCM3 as established driver genes, and more recently, PIK3CA and MAP3K3 have been identified as additional potential driver genes. Moreover, on the basis of genetic information, animal studies have developed model organisms, including murine models, that highly recapitulate human CCMs, facilitating the elucidation of molecular mechanisms. This article provides a brief overview of the epidemiology and aetiology of CCMs.
脑海绵状血管畸形(CCMs)是一种血管异常,在高达0.5%的人群中影响中枢神经系统。这些病变的特征是薄壁、扩张的血管,易发生出血。它们可引起多种症状,如癫痫发作、出血性中风和局灶性神经功能缺损。临床研究揭示了CCMs的流行病学和自然史。人类遗传学研究已确定CCM1、CCM2和CCM3为已确定的驱动基因,最近,PIK3CA和MAP3K3已被确定为其他潜在的驱动基因。此外,基于遗传信息,动物研究已开发出包括小鼠模型在内的模式生物,这些模式生物高度模拟人类CCMs,有助于阐明分子机制。本文简要概述了CCMs的流行病学和病因学。